Antiviral properties of lactoferrin--a natural immunity molecule
Open accessThe DOI matches its Crossref record; 152 of the 154 references it cites were found in a registry or an index.
Abstract
Lactoferrin, a multifunctional iron binding glycoprotein, plays an important role in immune regulation and defence mechanisms against bacteria, fungi and viruses. Lactoferrin's iron withholding ability is related to inhibition of microbial growth as well as to modulation of motility, aggregation and biofilm formation of pathogenic bacteria. Independently of iron binding capability, lactoferrin interacts with microbial, viral and cell surfaces thus inhibiting microbial and viral adhesion and entry into host cells. Lactoferrin can be considered not only a primary defense factor against mucosal infections, but also a polyvalent regulator which interacts in viral infectious processes. Its antiviral activity, demonstrated against both enveloped and naked viruses, lies in the early phase of infection, thus preventing entry of virus in the host cell. This activity is exerted by binding to heparan sulphate glycosaminoglycan cell receptors, or viral particles or both. Despite the antiviral effect of lactoferrin, widely demonstrated in vitro studies, few clinical trials have been carried out and the related mechanism of action is still under debate. The nuclear localization of lactoferrin in different epithelial human cells suggests that lactoferrin exerts its antiviral effect not only in the early phase of surface interaction virus-cell, but also intracellularly. The capability of lactoferrin to exert a potent antiviral activity, through its binding to host cells and/or viral particles, and its nuclear localization strengthens the idea that lactoferrin is an important brick in the mucosal wall, effective against viral attacks and it could be usefully applied as novel strategy for treatment of viral infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
![Figure 1 Structure of lactoferrin. From Baker and Baker [9].](https://figures.cochat.ai/paper-figures/62bf64f0774e481d88bcde9946b9a21e/antiviral-properties-of-lactoferrin-a-natural-immunity-molecule-figure-1.jpg)
![Figure 2 Iron binding site in the N-lobe of lactoferrin. From Baker and Baker [9].](https://figures.cochat.ai/paper-figures/b5cb674d94ef4143b1966c167ec89ce3/antiviral-properties-of-lactoferrin-a-natural-immunity-molecule-figure-2.jpg)
![Figure 3 Distribution of surface charge of human lactoferrin. Blue: positive; red: negative. From Baker and Baker [9].](https://figures.cochat.ai/paper-figures/b045aef14a004687ba00e44c335456b1/antiviral-properties-of-lactoferrin-a-natural-immunity-molecule-figure-3.jpg)

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Its concentration in plasma is low (0.2 µg/ml), but increases upon inflammation or infections due to the recruitment of neutrophil granulocytes”
From Iron in immune cell function and host defense (2021) · cites this paper as [68]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED ARTICLE: Inhibition of Tomato Yellow Leaf Curl Virus (TYLCV) using whey proteins
Abdelbacki, A. M. M., Taha, S. H., Sitohy, M. Z., Dawood, A. I. A., Abdel-Hamid, M., & Adel Abdel-Sabour, R. E. Z. K. (2010) · Virology Journal · doi:10.1186/1743-422x-7-26 · Cited by 50 · cited 1×
“Native and esterified lactoferrin showed complete inhibition after 7 days [151].”
BackgroundRetractedIsolation of a Common Receptor for Coxsackie B Viruses and Adenoviruses 2 and 5
Bergelson, J. M., Cunningham, J. A., Droguett, G., Kurt-Jones, E. A., Krithivas, A., Hong, J. S., Horwitz, M. S., Crowell, R. L., & Finberg, R. W. (1997) · Science · doi:10.1126/science.275.5304.1320 · Cited by 3,102
Integrins αvβ3 and αvβ5 promote adenovirus internalization but not virus attachment
Wickham, T. J., Mathias, P., Cheresh, D. A., & Nemerow, G. R. (1993) · Cell · doi:10.1016/0092-8674(93)90231-e · Cited by 2,199
Iron Metabolism in Pathogenic Bacteria
Ratledge, C., & Dover, L. G. (2000) · Annual Review of Microbiology · doi:10.1146/annurev.micro.54.1.881 · Cited by 1,539 · cited 1×
“The first is represented by the synthesis of small chelators, siderophores, which bind ferric iron with high affinity and transport it into bacteria through a specific receptor [41,42].”
BackgroundTomko, R. P., Xu, R., & Philipson, L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3352 · Cited by 1,200
Schaible, U. E., & Kaufmann, S. H. E. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro1046 · Cited by 945
Identification of the bactericidal domain of lactoferrin
Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., Kawase, K., & Tomita, M. (1992) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/0167-4838(92)90346-f · Cited by 892 · cited 1×
“This bactericidal activity of lactoferrin appears to be located in the N-terminal region as its derivative cationic peptide, called lactoferricin (Lfcin), is several fold more active than the intact protein [50-52].”
BackgroundLACTOFERRIN, AN IRON-BINBING PROTEIN NI NEUTROPHILIC LEUKOCYTES
Masson, P. L., Heremans, J. F., & Schonne, E. (1969) · The Journal of Experimental Medicine · doi:10.1084/jem.130.3.643 · Cited by 700
A Bactericidal Effect for Human Lactoferrin
Arnold, R. R., Cole, M. F., & McGhee, J. R. (1977) · Science · doi:10.1126/science.327545 · Cited by 676 · cited 1×
“A lactoferrin bactericidal iron independent effect was also described [44].”
BackgroundIron-binding Proteins in Milk and Resistance to Escherichia coli Infection in Infants
Bullen, J. J., Rogers, H. J., & Leigh, L. (1972) · BMJ · doi:10.1136/bmj.1.5792.69 · Cited by 655
Roelvink, P. W., Lizonova, A., Lee, J. G. M., Li, Y., Bergelson, J. M., Finberg, R. W., Brough, D. E., Kovesdi, I., & Wickham, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.10.7909-7915.1998 · Cited by 654
Anderson, B. F., Baker, H. M., Norris, G. E., Rice, D. W., & Baker, E. N. (1989) · Journal of Molecular Biology · doi:10.1016/0022-2836(89)90602-5 · Cited by 597 · cited 1×
“As is apparent from three dimensional (3D) structure of human lactoferrin (hLf) [7,8], the molecule is folded into two homologous lobes (N-lobe residues 1–333 and C-lobe residues 345–691).”
BackgroundBellamy, W., Takase, M., Wakabayashi, H., Kawase, K., & Tomita, M. (1992) · Journal of Applied Bacteriology · doi:10.1111/j.1365-2672.1992.tb05007.x · Cited by 588
An iron-binding protein common to many external secretions
Masson, P. L., Heremans, J. F., & Dive, C. H. (1966) · Clinica Chimica Acta · doi:10.1016/0009-8981(66)90004-0 · Cited by 577 · cited 1×
“The highest levels (~7 g/L) is found in human colostrum [28], while it is also present at lower levels in mature milk, in most exocrine secretions (Table 1), and in the secondary granules of mature neutrophils [29,30].”
BackgroundHerpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13799 · Cited by 567 · cited 2×
“sulfate or chondroitin sulfate or both, but was ineffective or less efficient in glycosaminoglycan deficient cells or in cells treated with glycosaminoglycan-degrading enzymes, suggesting that the anti-HSV-1 activity of lactoferrin is dependent on its interaction with cell surface glycosaminoglycan chains of heparan s…”
BackgroundDamage of the outer membrane of enteric gram-negative bacteria by lactoferrin and transferrin
Ellison, R. T., Giehl, T. J., & LaForce, F. M. (1988) · Infection and Immunity · doi:10.1128/iai.56.11.2774-2781.1988 · Cited by 538 · cited 1×
“positive bacteria is required for the lethal effect [45-47].”
BackgroundHuman lactotransferrin: amino acid sequence and structural comparisons with other transferrins
METZ-BOUTIGUE, M.-H., JOLLES, J., MAZURIER, J., SCHOENTGEN, F., LEGRAND, D., SPIK, G., MONTREUIL, J., & JOLLES, P. (1984) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1984.tb08607.x · Cited by 538 · cited 1×
“The amino acid sequence of hLf [10] has a high degree of identity with human transferrin (~60%), and the characteristic twofold internal sequence repeat suggests an ancestral gene duplication.”
BackgroundLactoferrin: Lactoferrin: an important host defence against microbial and viral attack
Valenti, P., & Antonini, G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5372-0 · Cited by 488
Self-citationHerpesviruses and heparan sulfate: an intimate relationship in aid of viral entry
Shukla, D., & Spear, P. G. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113799 · Cited by 454
Potent Antibacterial Peptides Generated by Pepsin Digestion of Bovine Lactoferrin
Tomita, M., Bellamy, W., Takase, M., Yamauchi, K., Wakabayashi, H., & Kawase, K. (1991) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(91)78608-6 · Cited by 445 · cited 1×
“This bactericidal activity of lactoferrin appears to be located in the N-terminal region as its derivative cationic peptide, called lactoferricin (Lfcin), is several fold more active than the intact protein [50-52].”
BackgroundLactoferrin in milk from different species
Masson, P. L., & Heremans, J. F. (1971) · Comparative Biochemistry and Physiology Part B: Comparative Biochemistry · doi:10.1016/0305-0491(71)90258-6 · Cited by 444 · cited 1×
“The highest levels (~7 g/L) is found in human colostrum [28], while it is also present at lower levels in mature milk, in most exocrine secretions (Table 1), and in the secondary granules of mature neutrophils [29,30].”
BackgroundLactoferrin: Molecular structure, binding properties and dynamics of lactoferrin
Baker, E. N., & Baker, H. M. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5368-9 · Cited by 387 · cited 4×
“Moreover, it has been demonstrated that Mn- or Zn- saturated forms maintain some physiological functions of lactoferrin, unrelated to its iron binding capability [20] but probably related to its three remarkable concentrations of positive charge: Residues 1–7, 13–30 and inter-lobe region, close to the connecting helix…”
BackgroundInfluentialStructure of human lactoferrin at 3.2-A resolution.
Anderson, B. F., Baker, H. M., Dodson, E. J., Norris, G. E., Rumball, S. V., Waters, J. M., & Baker, E. N. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.7.1769 · Cited by 386 · cited 1×
“As is apparent from three dimensional (3D) structure of human lactoferrin (hLf) [7,8], the molecule is folded into two homologous lobes (N-lobe residues 1–333 and C-lobe residues 345–691).”
BackgroundHarmsen, M. C., Swart, P. J., Bethune, M.-P. D., Pauwels, R., Clercq, E. D., The, T. B., & Meijer, D. K. F. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.380 · Cited by 379
The antimicrobial activity of lactoferrin: Current status and perspectives
Orsi, N. (2004) · Biometals · doi:10.1023/b:biom.0000027691.86757.e2 · Cited by 368 · cited 1×
“bricks of natural non-immune defences against microbial infections [38].”
BackgroundLactoferrin is a lipid A-binding protein
Appelmelk, B. J., An, Y. Q., Geerts, M., Thijs, B. G., de Boer, H. A., MacLaren, D. M., de Graaff, J., & Nuijens, J. H. (1994) · Infection and Immunity · doi:10.1128/iai.62.6.2628-2632.1994 · Cited by 362 · cited 4×
“However, the release of LPS can be annulled by high calcium concentration in the culture media [53].”
BackgroundInfluentialSequence specificity and transcriptional activation in the binding of lactoferrin to DNA
He, J., & Furmanski, P. (1995) · Nature · doi:10.1038/373721a0 · Cited by 354 · cited 4×
“Molecules 2011, 16 7003 Recently, Li et al. reported that bLf, and its iron-, and zinc-saturated forms significantly inhibited the amplification of HBV-DNA in a dose-dependent manner in HBV-infected HepG2 cells, while bLf hydrolysate were ineffective [106].”
BackgroundInfluentialThe Isolation of a Red Protein from Milk2
Groves, M. L. (1960) · Journal of the American Chemical Society · doi:10.1021/ja01498a029 · Cited by 353 · cited 1×
“Lactoferrin was identified in 1939 in bovine milk [1] and isolated in 1960 from both human [2,3] and bovine milk [4].”
BackgroundIsolation of an Iron-Containing Red Protein from Human Milk.
Johanson, B., Virtanen, A. I., Tweit, R. C., & Dodson, R. M. (1960) · Acta Chemica Scandinavica · doi:10.3891/acta.chem.scand.14-0510 · Cited by 301 · cited 1×
“Lactoferrin was identified in 1939 in bovine milk [1] and isolated in 1960 from both human [2,3] and bovine milk [4].”
BackgroundMAZURIER, J., & SPIK, G. (1980) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(80)90112-9 · Cited by 278 · cited 1×
“5 [5,6].”
Préparation et propriétés de la lactosidérophiline (lactotransferrine) du lait de femme
Montreuil, J., Tonnelat, J., & Mullet, S. (1960) · Biochimica et Biophysica Acta · doi:10.1016/0006-3002(60)91478-5 · Cited by 265
Heparan Sulfate Glycosaminoglycans Are Involved in Adenovirus Type 5 and 2-Host Cell Interactions
Dechecchi, M. C., Tamanini, A., Bonizzato, A., & Cabrini, G. (2000) · Virology · doi:10.1006/viro.1999.0171 · Cited by 260 · cited 1×
“adenovirus infection [127].”
MacGillivray, R. T. A., Moore, S. A., Chen, J., Anderson, B. F., Baker, H., Luo, Y., Bewley, M., Smith, C. A., Murphy, M. E. P., Wang, Y., et al. (1998) · Biochemistry · doi:10.1021/bi980355j · Cited by 228 · cited 2×
“The participation of the CO3 ion in the iron coordination binding appears to be ideal for iron reversible binding [6] since the protonation of CO3 ion is a likely first step in the breakup of the iron site at low pH [14].”
BackgroundMann, D. M., Romm, E., & Migliorini, M. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31566-1 · Cited by 227
Role of lactoferrin in the tear film
FLANAGAN, J., & WILLCOX, M. (2009) · Biochimie · doi:10.1016/j.biochi.2008.07.007 · Cited by 221 · cited 1×
“In tears, due to the high concentration of free lactoferrin, it is most likely that lactoferrin provides a protective role against viral adhesion and pathogenesis [137].”
BackgroundStructure and Reactivity of Transferrins
Baker, E. N. (1994) · Advances in Inorganic Chemistry · doi:10.1016/s0898-8838(08)60176-2 · Cited by 214 · cited 12×
“Furthermore, studies on mutant lactoferrin have shown that when Fe(III)-binding in the N-lobe is disabled, Fe(III)-binding in the C-lobe is unaffected, while, when binding in the C-lobe is disabled, Fe(III)-binding in the N-lobe is destabilized, occurring at pH ~5.0 [18].”
BackgroundInfluentialVAN BERKEL, P. H. C., GEERTS, E. J. M., VAN VEEN, A. H., MERICSKAY, M., DE BOER, A. H., & NUIJENS, H. J. (1997) · Biochemical Journal · doi:10.1042/bj3280145 · Cited by 211
Superti, F., Ammendolia, M. G., Valenti, P., & Seganti, L. (1997) · Medical Microbiology and Immunology · doi:10.1007/s004300050049 · Cited by 206 · cited 1×
“The anti-rotavirus effect of bLf was tested in cultured human intestinal cells (HT-29 cells), expressing the differentiation phenotype of mature enterocytes, the in vivo target of rotavirus infection [118].”
BackgroundSelf-citationLactoferrin and transferrin: Functional variations on a common structural framework
Baker, E. N., Baker, H. M., & Kidd, R. D. (2002) · Biochemistry and Cell Biology · doi:10.1139/o01-153 · Cited by 204 · cited 3×
“Spectroscopic studies and the 3D structure suggest that the CO3 ion binds first, thus neutralizing the positive charge of the arginine residue (Arg-121 in the N-lobe and Arg-465 in the C-lobe) [6,13].”
BackgroundAndersen, J. H., Osbakk, S. A., Vorland, L. H., Traavik, T., & Gutteberg, T. J. (2001) · Antiviral Research · doi:10.1016/s0166-3542(01)00146-2 · Cited by 182 · cited 2×
“Concerning lactoferricin, a pepsin-digested lactoferrin derivative, the antiviral activity of this highly positively charged loop domain of lactoferrin, was demonstrated for the first time by Andersen and co-workers [57] against human cytomegalovirus (HCMV) infection in vitro.”
BackgroundMethodEPIDEMIOLOGY OF EPIDEMIC KERATOCONJUNCTIVITIS
FORD, E., NELSON, K. E., & WARREN, D. (1987) · Epidemiologic Reviews · doi:10.1093/oxfordjournals.epirev.a036304 · Cited by 178
Bruns, C. M., Nowalk, A. J., Arvai, A. S., McTigue, M. A., Vaughan, K. G., Mietzner, T. A., & McRee, D. E. (1997) · Nature Structural & Molecular Biology · doi:10.1038/nsb1197-919 · Cited by 177
Transferrins: insights into structure and function from studies on lactoferrin
Baker, E. N., Rumball, S. V., & Anderson, B. F. (1987) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(87)90163-0 · Cited by 166 · cited 1×
“The iron sites are highly conserved in all iron-binding proteins, suggesting a common evolutionary origin [11,12].”
BackgroundHepatitis C virus envelope proteins bind lactoferrin
Yi, M., Kaneko, S., Yu, D. Y., & Murakami, S. (1997) · Journal of Virology · doi:10.1128/jvi.71.8.5997-6002.1997 · Cited by 163 · cited 1×
“lactoferrins and E1 and E2 HCV envelope proteins has been reported [91].”
BackgroundÖsterlund, P., Pirhonen, J., Ikonen, N., Rönkkö, E., Strengell, M., Mäkelä, S. M., Broman, M., Hamming, O. J., Hartmann, R., Ziegler, T., et al. (2010) · Journal of Virology · doi:10.1128/jvi.01619-09 · Cited by 162 · cited 1×
“It is believed that the magnitude of inflammation is a major contributing factor to viral disease severity [152].”
BackgroundINHIBITION WITH LACTOFERRIN OF IN VITRO INFECTION WITH HUMAN HERPES VIRUS
HASEGAWA, K., MOTSUCHI, W., TANAKA, S., & DOSAKO, S.-I. (1994) · Japanese Journal of Medical Science and Biology · doi:10.7883/yoken1952.47.73 · Cited by 159 · cited 2×
“The in vitro activity of hLf and bLf against human cytomegalovirus (HCMV) infection has been described in 1994 [55].”
BackgroundSørensen, M., & Sörensen, S. P. L. (1940) · Cited by 155
Lactoferrin levels in normal human tears.
Kijlstra, A., Jeurissen, S. H. M., & Koning, K. M. (1983) · British Journal of Ophthalmology · doi:10.1136/bjo.67.3.199 · Cited by 150 · cited 1×
“2 mg/mL [136].”
Andersen, J. H., Jenssen, H., Sandvik, K., & Gutteberg, T. J. (2004) · Journal of Medical Virology · doi:10.1002/jmv.20171 · Cited by 149 · cited 1×
“The same authors [70] demonstrated that also Lfcin was dependent on the presence of heparan sulfate at the cell surface to exert its antiviral activity.”
BackgroundLactoferrin Markedly Inhibits Hepatitis C Virus Infection in Cultured Human Hepatocytes
Ikeda, M., Sugiyama, K., Tanaka, T., Tanaka, K., Sekihara, H., Shimotohno, K., & Kato, N. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8481 · Cited by 149 · cited 1×
“It has been also demonstrated that pre-incubation of HCV with bLf inhibits viral infection, while cell pretreatment with bLf was ineffective [92].”
BackgroundIkeda, M., Nozaki, A., Sugiyama, K., Tanaka, T., Naganuma, A., Tanaka, K., Sekihara, H., Shimotohno, K., Saito, M., & Kato, N. (2000) · Virus Research · doi:10.1016/s0168-1702(99)00121-5 · Cited by 149 · cited 1×
“Further studies demonstrated that bLf inhibited HCV entry into the cells by interacting with viral particles immediately after mixing of bLf and HCV inoculum [93].”
BackgroundPuddu, P., Borghi, P., Gessani, S., Valenti, P., Belardelli, F., & Seganti, L. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00066-1 · Cited by 142 · cited 2×
“Both HIV-1 replication and syncytium formation were efficiently inhibited, in a dose-dependent manner, by apo- or holo-, Mn(II) and Zn(II)lactoferrin [83].”
BackgroundSelf-citationLactoferrin inhibits herpes simplex virus type 1 adsorption to Vero cells
Marchetti, M., Longhi, C., Conte, M. P., Pisani, S., Valenti, P., & Seganti, L. (1996) · Antiviral Research · doi:10.1016/0166-3542(95)00840-3 · Cited by 142 · cited 1×
“Both hLf and bLf were found to prevent HSV-1 and HSV-2 cytopathic effect and yield in Vero cells [60,61].”
BackgroundSelf-citationBiophysical Characterization of Lipopolysaccharide and Lipid A Inactivation by Lactoferrin
Brandenburg, K., Jürgens, G., Müller, M., Fukuoka, S., & Koch, M. H. J. (2001) · Biological Chemistry · doi:10.1515/bc.2001.152 · Cited by 140 · cited 4×
“However, the release of LPS can be annulled by high calcium concentration in the culture media [53].”
BackgroundInfluentialGroot, F., Geijtenbeek, T. B. H., Sanders, R. W., Baldwin, C. E., Sanchez-Hernandez, M., Floris, R., van Kooyk, Y., de Jong, E. C., & Berkhout, B. (2005) · Journal of Virology · doi:10.1128/jvi.79.5.3009-3015.2005 · Cited by 140 · cited 1×
“transmission, bLf turned out to be the most potent inhibitor [86].”
BackgroundSWART, P. J., KUIPERS, M. E., SMIT, C., PAUWELS, R., DE BÉTHUNE, M. P., DE CLERCQ, E., MEIJER, D. K. F., & HUISMAN, J. G. (1996) · AIDS Research and Human Retroviruses · doi:10.1089/aid.1996.12.769 · Cited by 139 · cited 1×
“Addition of negatively charged groups to lactoferrin by succinylation resulted in a strong antiviral effect on HIV-1 and HIV-2, while the addition of positive charges to lactoferrin through amination resulted in a loss of anti-HIV activity [58,81,82].”
BackgroundGrossmann, J. G., Neu, M., Pantos, E., Schwab, F. J., Evans, R. W., Townes-Andrews, E., Lindley, P. F., Appel, H., Thies, W.-G., & Hasnain, S. S. (1992) · Journal of Molecular Biology · doi:10.1016/0022-2836(92)90402-6 · Cited by 139 · cited 1×
“The iron-saturated form is closed and much more compact than the apo form [15].”
BackgroundRedwan, E. M. M. M., & Tabll, A. A. (2007) · Journal of Immunoassay and Immunochemistry · doi:10.1080/15321810701454839 · Cited by 137 · cited 1×
“In in vitro model, purified camel lactoferrin interacts with HCV, thus leading to a complete virus entry inhibition [104].”
BackgroundAndersen, J. H., Jenssen, H., & Gutteberg, T. J. (2003) · Antiviral Research · doi:10.1016/s0166-3542(02)00214-0 · Cited by 136 · cited 1×
“Andersen and co-workers [69] demonstrated that bovine Lfcin inhibited HSV-1 and HSV-2”
BackgroundLactoferrin Inhibits Hepatitis C Virus Viremia in Patients with Chronic Hepatitis C: A Pilot Study
Tanaka, K., Ikeda, M., Nozaki, A., Kato, N., Tsuda, H., Saito, S., & Sekihara, H. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00756.x · Cited by 136 · cited 1×
“Concerning in vivo studies, following the first pilot study of Tanaka and co-workers [97], a trial was”
ResultIron uptake and utilization by mammalian cells. I: Cellular uptake of transferrin and iron
Octave, J., Schneider, Y., Trouet, A., & Crichton, R. R. (1983) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(83)90217-7 · Cited by 136 · cited 1×
“For transferrin, the iron release at low pH is considered to be important for iron delivery to cells [16].”
BackgroundLactoferrin and transferrin damage of the Gram-negative outer membrane is modulated by Ca2+ and Mg2+
Ellison, R. T., LaForce, F. M., Giehl, T. J., Boose, D. S., & Dunn, B. E. (1990) · Journal of General Microbiology · doi:10.1099/00221287-136-7-1437 · Cited by 131
Inhibition of poliovirus type 1 infection by iron-, manganese- and zinc-saturated lactoferrin
Marchetti, M., Superti, F., Ammendolia, M. G., Rossi, P., Valenti, P., & Seganti, L. (1999) · Medical Microbiology and Immunology · doi:10.1007/s004300050093 · Cited by 128 · cited 4×
“Studies on poliovirus type 1 infection in Vero cells demonstrated that both bLf and hLf inhibited viral cytopathic effect with a dose-dependent relationship by interfering with an early step of viral infection [125].”
BackgroundResultInfluentialSelf-citationLactoferrin inhibits hepatitis B virus infection in cultured human hepatocytes
Hara, K., Ikeda, M., Saito, S., Matsumoto, S., Numata, K., Kato, N., Tanaka, K., & Sekihara, H. (2002) · Hepatology Research · doi:10.1016/s1386-6346(02)00088-8 · Cited by 127 · cited 1×
“As pre-incubation of HBV with bLf had no inhibitory effect on viral infection, these results suggested that bLf interaction with susceptible cells was important for its anti-HBV effect [105].”
ResultSuperti, F., Siciliano, R. A., Rega, B., Giansanti, F., Valenti, P., & Antonini, G. (2001) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(01)00178-7 · Cited by 112 · cited 15×
“Other studies investigated the role of metal binding, sialic acid and tryptic fragments of bLf in the activity towards rotavirus infection [119], Results obtained demonstrated that the effect of differently metal saturated lactoferrin was exerted during and after the viral attachment step, the removal of sialic acid e…”
BackgroundInfluentialSelf-citationBerkhout, B., van Wamel, J. L. B., Beljaars, L., Meijer, D. K. F., Visser, S., & Floris, R. (2002) · Antiviral Research · doi:10.1016/s0166-3542(02)00069-4 · Cited by 106 · cited 1×
“Studies on bLf-resistant HIV-1 variants showed that the viral envelope protein, which contains two mutations that are associated with an altered virus-host interaction and a modified receptor-co-receptor interaction, mediated the bLf resistance phenotype demonstrating that bLf targeted the HIV-1 entry process [85].”
BackgroundLactoferrin Inhibits Enterovirus 71 Infection of Human Embryonal Rhabdomyosarcoma Cells In Vitro
Lin, T., Chu, C., & Chiu, C. (2002) · The Journal of Infectious Diseases · doi:10.1086/343809 · Cited by 103 · cited 1×
“hLf and bLf were also assayed in vitro to assess their inhibiting capacity on the cytopathic effect of enterovirus 71 (EV71) on human embryonic rhabdomyosarcoma cells [143].”
BackgroundLactoferrin inhibits human papillomavirus binding and uptake in vitro
Drobni, P., Näslund, J., & Evander, M. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.05.005 · Cited by 101
Roelvink, P. W., Kovesdi, I., & Wickham, T. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.7614-7621.1996 · Cited by 100 · cited 1×
“The infection of adenovirus serotype 5 (species C), a common human pathogen exploited as a viral vector for gene therapy and vaccination, involves binding of the viral fiber knob to CAR on the target cells [132], followed by an interaction between the viral penton base with integrins on the cell surface [133].”
BackgroundMarchetti, M., Trybala, E., Superti, F., Johansson, M., & Bergström, T. (2004) · Virology · doi:10.1016/j.virol.2003.09.029 · Cited by 100 · cited 1×
“Marchetti and co-workers [66] demonstrated that bLf was a strong inhibitor of HSV-1 infection in cells expressing either heparan”
BackgroundJenssen, H., Andersen, J. H., Uhlin‐Hansen, L., Gutteberg, T. J., & Rekdal, Ø. (2003) · Antiviral Research · doi:10.1016/j.antiviral.2003.09.001 · Cited by 100 · cited 1×
“Other studies demonstrated that lactoferrin and several of the Lfcin derivatives exhibited similar affinity for heparan sulfate, but the lactoferrin proteins were more active compared with the smaller peptides [71].”
ResultLactoferrin inhibits herpes simplex virus type-1 (HSV-1) infection to mouse cornea
Fujihara, T., & Hayashi, K. (1995) · Archives of Virology · doi:10.1007/bf01322673 · Cited by 99
Marchetti, M., Pisani, S., Antonini, G., Valenti, P., Seganti, L., & Orsi, N. (1998) · BioMetals · doi:10.1023/a:1009217709851 · Cited by 97 · cited 3×
“metal ion saturated forms [Fe(III)-, Mn(II)-, Zn(II)-lactoferrin] and results of this study showed that the antiviral effect of the differently saturated bLf towards both viruses was mainly exerted during the initial viral adsorption phase [61].”
BackgroundSelf-citationChien, Y.-J., Chen, W., Hsu, W., & Chiou, S. (2008) · Virology · doi:10.1016/j.virol.2008.06.017 · Cited by 97 · cited 1×
“This finding provided evidence to suggest that also cell surface-expressed low-density lipoprotein receptor LDLR may play a role in JEV infection [150].”
BackgroundShimizu, K., Matsuzawa, H., Okada, K., Tazume, S., Dosako, S., Kawasaki, Y., Hashimoto, K., & Koga, Y. (1996) · Archives of Virology · doi:10.1007/bf01718201 · Cited by 95 · cited 1×
“Concerning in vivo studies against CMV, experiments in BALB/c mice showed that the administration of bLf, before murine CMV infection, completely protected mice from death [75].”
BackgroundAntiadenovirus activity of milk proteins: lactoferrin prevents viral infection
Arnold, D., Biase, A. M. D., Marchetti, M., Pietrantoni, A., Valenti, P., Seganti, L., & Superti, F. (2002) · Antiviral Research · doi:10.1016/s0166-3542(01)00197-8 · Cited by 94 · cited 2×
“These data are conflicting with those showing an antiviral effect against adenovirus by both hLf and bLf [124,126].”
BackgroundResultSelf-citationIn vitro antiviral activity of lactoferrin and ribavirin upon hantavirus
Murphy, M. E., Kariwa, H., Mizutani, T., Yoshimatsu, K., Arikawa, J., & Takashima, I. (2000) · Archives of Virology · doi:10.1007/s007050070077 · Cited by 91 · cited 1×
“Hantaviral foci number, in cultured cells infected with SR-11, was reduced with bLf treatment [112].”
BackgroundSano, H., Nagai, K., Tsutsumi, H., & Kuroki, Y. (2003) · European Journal of Immunology · doi:10.1002/eji.200324218 · Cited by 90 · cited 2×
“To clarify the mechanism of this effect, the interaction of lactoferrin with RSV F protein, the most important surface glycoprotein for viral penetration, was examined and results obtained showed that lactoferrin directly interacted with the F (1) subunit, which involved antigenic sites of F protein [109].”
BackgroundRado, T., Wei, X., & Benz, E. J. (1987) · Blood · doi:10.1182/blood.v70.4.989.989 · Cited by 90 · cited 1×
“varies from 23 to 35 kb among human [23-25] and bovine species [26].”
BackgroundMcCann, K. B., Lee, A., Wan, J., Roginski, H., & Coventry, M. J. (2003) · Journal of Applied Microbiology · doi:10.1046/j.1365-2672.2003.02071.x · Cited by 88 · cited 1×
“susceptible cells, thereby preventing the attachment of the virus particles [122].”
BackgroundRossi, P., Giansanti, F., Boffi, A., Ajello, M., Valenti, P., Chiancone, E., & Antonini, G. (2002) · Biochemistry and Cell Biology · doi:10.1139/o01-209 · Cited by 86
Self-citationSiciliano, R. A., Rega, B., Marchetti, M., Seganti, L., Antonini, G., & Valenti, P. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1318 · Cited by 84 · cited 2×
“In the attempt to identify the regions of lactoferrin responsible for the anti-HSV-1 activity, the inhibiting effect of peptide fragments, derived from the tryptic digestion of bLf, were also analyzed [62].”
BackgroundSelf-citationBovine Lactoferrin Inhibits Adenovirus Infection by Interacting with Viral Structural Polypeptides
Pietrantoni, A., Di Biase, A. M., Tinari, A., Marchetti, M., Valenti, P., Seganti, L., & Superti, F. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.8.2688-2691.2003 · Cited by 83 · cited 1×
“This antiviral activity of bLf occurs through bLf interaction with adenovirus particles and in particular, with the adenovirus penton base (polypeptide III), the protein responsible for viral attachment to the integrin cell receptors [128].”
BackgroundSelf-citationThe anti-papillomavirus activity of human and bovine lactoferricin
Mistry, N., Drobni, P., Näslund, J., Sunkari, V. G., Jenssen, H., & Evander, M. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2007.03.012 · Cited by 83 · cited 16×
“Lactoferrin and Lfcin agaist HSV-1 cellular uptake and intracellular trafficking were further studied by immunofluorescence microscopy.”
BackgroundInfluentialThe Development of Awareness of Iron-Withholding Defense
Weinberg, E. D. (1993) · Perspectives in Biology and Medicine · doi:10.1353/pbm.1993.0063 · Cited by 81 · cited 1×
“This action of lactoferrin was considered bacteriostatic, as reversible by the addition of ferric iron [40].”
BackgroundInhibition of cytomegalovirus infection by lactoferrin in vitro and in vivo
BELJAARS, L., VANDERSTRATE, B., BAKKER, H., REKERSMIT, C., VANLOENENWEEMAES, A., WIEGMANS, F., HARMSEN, M., MOLEMA, G., & MEIJER, D. (2004) · Antiviral Research · doi:10.1016/j.antiviral.2004.05.002 · Cited by 78 · cited 2×
“Successively other authors confirmed that lactoferrin inhibit the early steps of cytomegalovirus infection and that the antiviral effect is due to its cationic properties [59].”
ResultHeparin‐interacting sites of bovine lactoferrin are involved in anti‐adenovirus activity
Di Biase, A. M., Pietrantoni, A., Tinari, A., Siciliano, R., Valenti, P., Antonini, G., Seganti, L., & Superti, F. (2003) · Journal of Medical Virology · doi:10.1002/jmv.10337 · Cited by 78 · cited 2×
“These data are conflicting with those showing an antiviral effect against adenovirus by both hLf and bLf [124,126].”
BackgroundResultSelf-citationAntiviral Activity of Lactoferrin
Valenti, P., Marchetti, M., Superti, F., Ammendolia, M. G., Puddu, P., Gessani, S., Borghi, P., Belardelli, F., Antonini, G., & Seganti, L. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4757-9068-9_23 · Cited by 77
Self-citationBreastfeeding and chronic HBV infection: Clinical and social implications
Petrova, M., & Kamburov, V. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i40.5042 · Cited by 77 · cited 1×
“HBV [107].”
Johansson, C., Jönsson, M., Marttila, M., Persson, B. D., Fan, X., Skog, J., Frängsmyr, L., Wadell, G., & Arnberg, N. (2006) · Journal of Virology · doi:10.1128/jvi.01995-06 · Cited by 77 · cited 2×
“Conversely, commercial hLf (Sigma-Aldrich) was found to promote adenoviral infection of corneal epithelial cells [138] as well as hLf or bLf from milk or recombinant hLf from rice to enhance adenoviral infection of some myeloid cells [139] This paradoxical enhancement of adenoviral infection by lactoferrin should be e…”
BackgroundNozaki, A., Ikeda, M., Naganuma, A., Nakamura, T., Inudoh, M., Tanaka, K., & Kato, N. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207879200 · Cited by 77 · cited 2×
“Nozaki and co-workers [94] better characterized the binding activity of lactoferrin to hepatitis C virus E2 envelope protein and determined the region of lactoferrin important for this activity.”
BackgroundLi, L., Hangoc, G., Oliff, A. I., Chen, L. T., Shen, R., & Broxmeyer, H. E. (1987) · PubMed · Cited by 76
Day, C. L., Stowell, K. M., Baker, E. N., & Tweedie, J. W. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49647-6 · Cited by 75 · cited 1×
“0 [17], similarly to transferrin (pH 5.”
Lactoferrin gene promoter: structural integrity and nonexpression in HL60 cells
Johnston, J., Rintels, P., Chung, J., Sather, J., Benz, E. J., & Berliner, N. (1992) · Blood · doi:10.1182/blood.v79.11.2998.2998 · Cited by 74
Shust, G. F., Cho, S., Kim, M., Madan, R. P., Guzman, E. M., Pollack, M., Epstein, J., Cohen, H. W., Keller, M. J., & Herold, B. C. (2010) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2009.00768.x · Cited by 74 · cited 1×
“Recently, it has been also reported that cervicovaginal lavage differently inhibited HSV infection by a mean value of approximately 57% during the follicular or luteal phase, but only by 36% in hormonal contraceptive users [78].”
BackgroundJameson, G. B., Anderson, B. F., Norris, G. E., Thomas, D. H., & Baker, E. N. (1998) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444998004417 · Cited by 73
Antiviral activity of human lactoferrin: inhibition of alphavirus interaction with heparan sulfate
Waarts, B.-L., Aneke, O. J. C., Smit, J. M., Kimata, K., Bittman, R., Meijer, D. K. F., & Wilschut, J. (2005) · Virology · doi:10.1016/j.virol.2005.01.010 · Cited by 72 · cited 2×
“sulfate-adapted viral strains suggesting that hLf inhibited infection of heparan sulfate-adapted alphavirus by interfering with virus-receptor interaction [111].”
BackgroundMethodKaito, M., Iwasa, M., Fujita, N., Kobayashi, Y., Kojima, Y., Ikoma, J., Imoto, I., Adachi, Y., Hamano, H., & Yamauchi, K. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04858.x · Cited by 71 · cited 1×
“patients with chronic hepatitis C [103].”
Long-term follow-up of chronic hepatitis C patients treated with oral lactoferrin for 12 months
Ishii, K. (2003) · Hepatology Research · doi:10.1016/s1386-6346(02)00279-6 · Cited by 71 · cited 1×
“In a successive study the effects of long-term oral administration of bLf on serum parameters in patients with chronic hepatitis C have been analyzed and results obtained suggested that oral administration of lactoferrin induced a Th1-cytokine dominant environment in the peripheral blood so favouring the eradication o…”
BackgroundBacterial Iron Transport Related to Virulence
Braun, V. (2004) · Contributions to Microbiology · doi:10.1159/000081697 · Cited by 69 · cited 1×
“The first is represented by the synthesis of small chelators, siderophores, which bind ferric iron with high affinity and transport it into bacteria through a specific receptor [41,42].”
BackgroundBiological and Clinical Significance of Endotoxemia in the Course of Hepatitis C Virus Infection
Caradonna, L., Mastronardi, M., Magrone, T., Cozzolongo, R., Cuppone, R., Manghisi, O., Caccavo, D., Pellegrino, N., Amoroso, A., Jirillo, E., et al. (2002) · Current Pharmaceutical Design · doi:10.2174/1381612024606983 · Cited by 66 · cited 1×
“This interaction inhibited the binding of lipopolysaccharide to lipopolysaccharide-binding protein, thus preventing its fixation to CD14 (+) cells and leading to a reduced release of pro-inflammatory cytokines [101].”
BackgroundAdams, W. C. T., Bond, E., Havenga, M. J. E., Holterman, L., Goudsmit, J., Hedestam, G. B. K., Koup, R. A., & Loré, K. (2009) · Journal of General Virology · doi:10.1099/vir.0.008342-0 · Cited by 65
WAKABAYASHI, H., KUROKAWA, M., SHIN, K., TERAGUCHI, S., TAMURA, Y., & SHIRAKI, K. (2004) · Bioscience, Biotechnology, and Biochemistry · doi:10.1271/bbb.68.537 · Cited by 64 · cited 1×
“The influence of bLf feeding on the HSV-1 cutaneous infection of mice has been evaluated and results of this study, in which mice were infected with HSV-1 ten days after lactoferrin administration, showed that lactoferrin inhibited the appearance of skin lesions [77].”
BackgroundDose‐response Trial of Lactoferrin in Patients with Chronic Hepatitis C
Okada, S., Tanaka, K., Sato, T. S., Ueno, H., Saito, S., Okusaka, T., Sato, K., Yamamoto, S., & Kakizoe, T. (2002) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.2002.tb02484.x · Cited by 64
Enhanced antimicrobial activity of lactoferrin by binding to the bacterial surface.
Dalmastri, C., Valenti, P., Visca, P., Vittorioso, P., & Orsi, N. (1988) · PubMed · Cited by 63
Self-citationInhibition of HSV cell-to-cell spread by lactoferrin and lactoferricin
Jenssen, H., Sandvik, K., Andersen, J. H., Hancock, R. E. W., & Gutteberg, T. J. (2008) · Antiviral Research · doi:10.1016/j.antiviral.2008.03.004 · Cited by 62 · cited 16×
“Lactoferrin and Lfcin agaist HSV-1 cellular uptake and intracellular trafficking were further studied by immunofluorescence microscopy.”
BackgroundInfluentialJameson, G. B., Anderson, B. F., Norris, G. E., Thomas, D. H., & Baker, E. N. (1999) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444999094317 · Cited by 62 · cited 1×
“Therefore, the lactoferrin structure suggests that the C-terminal helix, which contacts the N-lobe close to the hinge, plays a very important role [19].”
BackgroundPanella, T. J., Liu, Y., Huang, A. T., & Teng, C. T. (1991) · PubMed · Cited by 58
CLARKE, N. M., & MAY, J. T. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-8-719 · Cited by 58 · cited 1×
“Lactoferrin did not inhibit rhinoviruses, while human milk decreased the growth of some of the rhinoviruses [147].”
BackgroundMurphy, M. E., Kariwa, H., Mizutani, T., Tanabe, H., Yoshimatsu, K., Arikawa, J., & Takashima, I. (2001) · Journal of Veterinary Medical Science · doi:10.1292/jvms.63.637 · Cited by 57 · cited 2×
“These results suggested that both lactoferrin and Rbv were efficacious in the treatment of hantavirus infection in vivo [114].”
BackgroundResultMarr, A. K., Jenssen, H., Moniri, M. R., Hancock, R. E. W., & Panté, N. (2008) · Biochimie · doi:10.1016/j.biochi.2008.05.016 · Cited by 56 · cited 1×
“Thus, in addition to their interference with the uptake of the virus into host cells, lactoferrin and Lfcin also exert their antiviral effect intracellularly [73,74].”
BackgroundChen, H., Wang, L.-C., Chang, C.-H., Yen, C., Cheng, W. T.-K., Wu, S., Hung, C.-M., Kuo, M. F., & Chen, C. (2008) · Vaccine · doi:10.1016/j.vaccine.2007.12.013 · Cited by 56
Ward, P. P., Zhou, X., & Conneely, O. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.22.12790 · Cited by 55
Bovine lactoferrin inhibits Influenza A virus induced programmed cell death in vitro
Pietrantoni, A., Dofrelli, E., Tinari, A., Ammendolia, M. G., Puzelli, S., Fabiani, C., Donatelli, I., & Superti, F. (2010) · BioMetals · doi:10.1007/s10534-010-9323-3 · Cited by 53 · cited 2×
“Similarly to that first demonstrated in echovirus 6, bLf treatment inhibited programmed cell death by interfering with function of caspase 3, a major virus induced apoptosis effector, as well as blocked nuclear export of viral ribonucleoproteins so preventing viral assembly [148].”
BackgroundNg, T. B., Lam, T. L., Au, T. K., Ye, X. Y., & Wan, C. C. (2001) · Life Sciences · doi:10.1016/s0024-3205(01)01311-x · Cited by 51 · cited 1×
“Other studies demonstrated that bLf strongly inhibited viral reverse transcriptase but only slightly inhibited HIV-1 protease and integrase [84].”
BackgroundLactoferrin inhibits HIV-1 replication in vitro and exhibits synergy when combined with zidovudine
Viani, R. M., Gutteberg, T. J., Lathey, J. L., & Spector, S. A. (1999) · AIDS · doi:10.1097/00002030-199907090-00018 · Cited by 50 · cited 1×
“Finally, a synergy between lactoferrin in combination with Zidovudine against HIV-1 replication in vitro, has been reported [87].”
BackgroundVälimaa, H., Tenovuo, J. O., Waris, M. E., & Hukkanen, V. (2009) · Virology Journal · doi:10.1186/1743-422x-6-53 · Cited by 49 · cited 1×
“Concerning hLf, in addition to inhibiting the adsorption and post-attachment events of HSV-1 infection, hLf is also able to neutralize HSV-1 and that the inhibition of cell-to-cell spread involves viral gD [68].”
BackgroundBovine Lactoferrin Receptors in Staphylococcus aureus Isolated from Bovine Mastitis
Naidu, A. S., Anderson, M., Międzobrodzki, J., Forsgren, A., & Watts, J. L. (1991) · Journal of Dairy Science · doi:10.3168/jds.s0022-0302(91)78277-5 · Cited by 48 · cited 1×
“Unlike transferrin, the capability of lactoferrin to retain iron at acid pH, which characterizes infection and inflammation sites, together with its cationic nature (pI ~ 9) may be responsible for its ability to bind to various microbial and viral negative surface structures [31-33], and to anionic”
BackgroundPortelli, J., Gordon, A., & May, J. T. (1998) · Journal of Medical Microbiology · doi:10.1099/00222615-47-11-1015 · Cited by 47
Lactoferrin receptors in Gram-negative bacteria: Insights into the iron acquisition process
Ekins, A., Khan, A. G., Shouldice, S. R., & Schryvers, A. B. (2004) · BioMetals · doi:10.1023/b:biom.0000027698.43322.60 · Cited by 46 · cited 1×
“The iron is bound by a periplasmic iron-binding protein, FbpA, and transported into the cell via an inner membrane complex comprised of FbpB and FbpC [43].”
BackgroundInhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin
Li, S., Zhou, H., Huang, G., & Liu, N. (2008) · Medical Microbiology and Immunology · doi:10.1007/s00430-008-0100-7 · Cited by 44 · cited 1×
“reported that bLf, and its iron-, and zinc-saturated forms significantly inhibited the amplification of HBV-DNA in a dose-dependent manner in HBV-infected HepG2 cells, while bLf hydrolysate were ineffective [106].”
BackgroundStructure of the Human Lactoferrin Gene and Its Chromosomal Localization
Kim, S. J., Yu, D., Pak, K.-W., Jeong, S., Kim, S. W., & Lee, K.-K. (1998) · Molecules and Cells · doi:10.1016/s1016-8478(23)13480-7 · Cited by 44 · cited 1×
“3 [21], while bLf gene is localized to chromosome 22 and syntenic group U12 [22].”
BackgroundEffects of bovine lactoferrin on in vitro replication of feline herpesvirus
Beaumont, S., Maggs, D. J., & Clarke, H. E. (2003) · Veterinary Ophthalmology · doi:10.1046/j.1463-5224.2003.00301.x · Cited by 42 · cited 1×
“Concerning animal herpes virus, it has been reported that exposure of susceptible cells to bLf prior or during viral adsorption strongly inhibited feline herpes virus 1 (FHV-1) replication [79].”
BackgroundThe bovine lactoferrin gene (LTF) maps to Chromosome 22 and syntenic group U12
Schwerin, M., Toldo, S. S., Eggen, A., Brunner, R. M., Seyfert, H., & Fries, R. (1994) · Mammalian Genome · doi:10.1007/bf00369317 · Cited by 41 · cited 1×
“3 [21], while bLf gene is localized to chromosome 22 and syntenic group U12 [22].”
BackgroundEffectiveness of esterified whey proteins fractions against Egyptian Lethal Avian Influenza A (H5N1)
Taha, S. H., Mehrez, M. A., Sitohy, M. Z., Abou Dawood, A. G. I., Abd-El Hamid, M. M., & Kilany, W. H. (2010) · Virology Journal · doi:10.1186/1743-422x-7-330 · Cited by 41 · cited 1×
“a-Lactalbumin had less antiviral activity even after esterification [149].”
BackgroundUeno, H., Sato, T. S., Yamamoto, S., Tanaka, K., Ohkawa, S., Takagi, H., Yokosuka, O., Furuse, J., Saito, H., Sawaki, A., et al. (2006) · Cancer Science · doi:10.1111/j.1349-7006.2006.00274.x · Cited by 41
Pérez-Cano, F. J., Marín-Gallén, S., Castell, M., Rodrı́guez-Palmero, M., Rivero, M., Castellote, C., & Franch, À. (2008) · Journal of Nutrition · doi:10.3945/jn.108.093856 · Cited by 41 · cited 1×
“lactoferrin reduces the severity of rotavirus-induced acute gastroenteritis and modulates the immune response against the pathogen [121].”
BackgroundAmmendolia, M. G., Pietrantoni, A., Tinari, A., Valenti, P., & Superti, F. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.09.002 · Cited by 39 · cited 1×
“Taken together the results of these studies, the inhibition of echovirus 6 infectivity by lactoferrin seems to be dependent on its interaction not only with cell surface glycosaminoglycan chains but also with viral structural proteins, demonstrating that this glycoprotein targets the virus entry process [146].”
ResultSelf-citationIron transport across Caco-2 cell monolayers. Effect of transferrin, lactoferrin and nitric oxide
Sánchez, L., Ismail, M., Liew, F. Y., & Brock, J. H. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(95)00173-5 · Cited by 37 · cited 1×
“this phenomenon could be mediated by the intracellular delivery of metal ions, already demonstrated for iron saturated lactoferrin [140], has been investigated.”
BackgroundRegulation of lactoferrin gene expression by estrogen and epidermal growth factor
Teng, C. T. (1999) · Cell Biochemistry and Biophysics · doi:10.1007/bf02738154 · Cited by 35 · cited 1×
“The hLf and bLf promoters contain a non-canonical TATA box, but only hLf has multiple steroid hormone response elements, while none are found in the other species studied, suggesting that the lactoferrin gene is differentially regulated among different species by steroid hormones [27].”
BackgroundInhibitory activity of bovine lactoferrin against echovirus induced programmed cell death in vitro
Tinari, A., Pietrantoni, A., Ammendolia, M. G., Valenti, P., & Superti, F. (2005) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2005.02.011 · Cited by 34 · cited 3×
“Lactoferrin antiviral activity is also associated to the prevention of Echovirus 6- and H3N2 influenza virus-induced apoptosis [145,148].”
BackgroundSelf-citationAntiviral activity of lactoferrin against canine herpesvirus
Tanaka, T., Nakatani, S., Xuan, X., Kumura, H., Igarashi, I., & Shimazaki, K. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00157-8 · Cited by 30 · cited 1×
“Other studies demonstrated that both the apo- and holo-lactoferrin inhibited canine herpes virus multiplication in Madin-Darby canine kidney (MDCK) cells [80].”
BackgroundAntiviral effect of human saliva against hantavirus
Hardestam, J., Pettersson, L., Ahlm, C., Evander, M., Lundkvist, Å., & Klingström, J. (2008) · Journal of Medical Virology · doi:10.1002/jmv.21332 · Cited by 29
Characterization of a first bovine lactoferrin gene variant, based on an EcoRI polymorphism
Seyfert, H., & Kühn, C. (1994) · Animal Genetics · doi:10.1111/j.1365-2052.1994.tb00059.x · Cited by 29 · cited 1×
“varies from 23 to 35 kb among human [23-25] and bovine species [26].”
BackgroundRatka, M., Lackmann, M., Ueckermann, C., Karlins, U., & Koch, G. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3954-3960.1989 · Cited by 22 · cited 1×
“virus was significantly affected [142].”
Abe, K., Nozaki, A., Tamura, K., Ikeda, M., Naka, K., Dansako, H., Hoshino, H., Tanaka, K., & Kato, N. (2007) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2007.tb03882.x · Cited by 22 · cited 1×
“reagents [95].”
Marchetti, M., Ammendolia, M. G., & Superti, F. (2008) · Biochimie · doi:10.1016/j.biochi.2008.04.015 · Cited by 19
Günther, P. S., Mikeler, E., Hamprecht, K., Schneider‐Schaulies, J., Jahn, G., & Dennehy, K. M. (2011) · Journal of General Virology · doi:10.1099/vir.0.030965-0 · Cited by 19
Interaction of lactoferrin with Escherichia coli cells and correlation with antibacterial activity
Visca, P., Dalmastri, C., Verzili, D., Antonini, G., Chiancone, E., & Valenti, P. (2004) · Medical Microbiology and Immmunology · doi:10.1007/bf00189610 · Cited by 18 · cited 1×
“positive bacteria is required for the lethal effect [45-47].”
BackgroundSelf-citationLü, L., Shen, R., Sz, Z., Srivastava, C. H., Harrington, M., Miyazawa, K., Wu, B., Zh, L., Ruscetti, S. K., & Broxmeyer, H. E. (1991) · PubMed · Cited by 18
Seganti, L., Biase, A. M. D., Rega, B., Giulio, B. D., Nicoletti, M., Antonini, G., & Valenti, P. (2001) · International Journal of Immunopathology and Pharmacology · doi:10.1177/039463200101400202 · Cited by 17 · cited 1×
“Two negatively charged small peptides deriving from N-lobe, previously shown effective on HSV-1 infection, have been further studied and results of this research demonstrated that the net negative charge of these peptides was not responsible for the antiviral activity [64].”
BackgroundSelf-citationStructure and activity of lactoferrin - a multi-functional protective agent for human health.
Superti, F., Berlutti, F., Paesano, R., Valenti, P., & Fuchs, H. (2008) · IRIS Research product catalog (Sapienza University of Rome) · Cited by 17
Self-citationCharacterization of a first bovine lactoferrin gene variant, based on an EcoRI polymorphism
Seyfert, H., & Kühn, C. (1994) · Animal Genetics · doi:10.1111/j.1365-2052.1994.tb00451.x · Cited by 17
Chen, L. T., Lu, L., & Broxmeyer, H. E. (1987) · PubMed · Cited by 16
Inhibitory Effect of Bovine Lactoferrin on Human Parainfluenza Virus Type 2 Infection
Yamamoto, H., Ura, Y., Tanemura, M., Koyama, A., Takano, S., Uematsu, J., Kawano, M., Tsurudome, M., O’Brien, M., & Komada, H. (2010) · Eisei kagaku · doi:10.1248/jhs.56.613 · Cited by 16 · cited 1×
“Concerning PIV, Lf exhibits antiviral activity against hPIV-2 by inhibiting virus adsorption to the surface of the cells thus preventing viral infection and replication [110].”
BackgroundCharacterization of SA‐11 rotavirus receptorid structures on human colon carcinoma cell line HT‐29
Superti, F., & Donelli, G. (1995) · Journal of Medical Virology · doi:10.1002/jmv.1890470421 · Cited by 16 · cited 1×
“Although the antiviral activity was mediated by the N-lobe [119], it was hypothesized that bLf prevention of viral attachment was not related to a competition for common binding sites on HT-29 cells, since the rotavirus strain utilized in this study binds to glycidic residues different from glycosaminoglycans [120], a…”
BackgroundKobayashi, S., Reeko, S. A. T. O., Takako, A. O. K. I., Omoe, K., Inanami, O., Hankanga, C., Yamada, Y., TOMIZAWA, N., Yasuda, J., & Sasaki, J. (2008) · Journal of Veterinary Medical Science · doi:10.1292/jvms.70.429 · Cited by 13 · cited 1×
“lymphocytes by modulating the cell proliferation, cell cycle and cytokines expression as shown in cats in terminal stage of FIV infection [88].”
BackgroundRangel, L. M., Fernandez-Tomas, C. B., Dahmus, M. E., & Gariglio, P. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)77627-3 · Cited by 12
Helical Peptides Derived from Lactoferrin Bind Hepatitis C Virus Envelope Protein E2
Beleid, R., Douglas, D. N., Kneteman, N. M., & Kaur, K. (2008) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2008.00715.x · Cited by 11 · cited 1×
“Other two helical peptides deriving from lactoferrin were found to bind hepatitis C virus envelope protein E2 [96].”
BackgroundAntiviral activity of lactoferrin derived peptides
Valenti, P., Antonini, G., Siciliano, R. A., Rega, B., Superti, F., Marchetti, M., Ammendolia, M. G., Seganti, L., SHIMAZAKI, K., Tsuda, H., et al. (2000) · Iris (Roma Tre University) · Cited by 8
Self-citationPeggion, C., Formaggio, F., Crisma, M., Toniolo, C., Kaptein, B., Broxterman, Q. B., & Kamphuis, J. (1999) · Journal of Peptide Science · doi:10.1002/(sici)1099-1387(199912)5:12<563::aid-psc226>3.0.co;2-3 · Cited by 6 · cited 1×
“Addition of negatively charged groups to lactoferrin by succinylation resulted in a strong antiviral effect on HIV-1 and HIV-2, while the addition of positive charges to lactoferrin through amination resulted in a loss of anti-HIV activity [58,81,82].”
BackgroundAmati, L., Cozzolongo, R., Manghisi, O. G., Cuppone, R., Pellegrino, N. M., Caccavo, D., & Jirillo, E. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043384231 · Cited by 5 · cited 1×
“It has also been demonstrated that an elevated percentage of HCV infected patients were endotoxemic [100].”
Background
Research works printed but not linked: 4
- Shimazaki, K., Tsuda, H., Tomita, M., Kuwata, T., and Perraudin, J.P. (2000). Lactoferrin: Structure, Function, and Applications, Elsevier Science Ltd.
- Degener, 2006, Lactoferrin inhibits human BK polyomavirus adsorption to Vero cells, Biochem. Cell Biol., 84, 389
- Pan, 2007, Biological properties of lactoferrin: An overview, Aust. J. Dairy Technol., 62, 31
- Ammendolia, 2007, Bovine lactoferrin inhibits echovirus endocytic pathway by interacting with viral structural polypeptides, Antiviral Res., 73, 151, 10.1016/j.antiviral.2006.09.002 · DOI
Cited by
The human virome: assembly, composition and host interactions
Liang, G., & Bushman, F. D. (2021) · Nature Reviews Microbiology · doi:10.1038/s41579-021-00536-5 · Cited by 624
Intracellular Pathogens: Host Immunity and Microbial Persistence Strategies
Thakur, A., Mikkelsen, H., & Jungersen, G. (2019) · Journal of Immunology Research · doi:10.1155/2019/1356540 · Cited by 396
Lactoferrin: a natural Glycoprotein involved in iron and inflammatory homeostasis
Rosa, L., Cutone, A., Lepanto, M., Paesano, R., & Valenti, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18091985 · Cited by 376
“This activity is mainly due to bLf binding to GAGs and HS or viral particles or both ([111] and references therein), thus inhibiting viral entry into host cells.”
BackgroundSelf-citationTear analysis in ocular surface diseases
Zhou, L., & Beuerman, R. W. (2012) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2012.06.002 · Cited by 318
Immunomodulatory effects of lactoferrin
Siqueiros-Cendón, T., Arévalo-Gallegos, S., Iglesias-Figueroa, B. F., García-Montoya, I. A., Salazar-Martínez, J., & Rascón-Cruz, Q. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.200 · Cited by 316
Metadata
- Authors
- Berlutti, F., Pantanella, F., Natalizi, T., Frioni, A., Paesano, R., Polimeni, A., & Valenti, P.
- Affiliations
- Sapienza University of Rome (IT)
- Corresponding author
- Valenti, Piera
- Venue
- Molecules
- Publisher
- MDPI AG
- Published
- 2011-08-16
- Volume
- 16
- Issue
- 8
- Pages
- 6992-7018
- ISSN
- 1420-3049 (ISSN-L)
- PMC
- PMC6264778
- OpenAlex
- W2048747284
- Cited by
- 356
- References
- 154
- Citations by year
- 2026: 8 · 2025: 23 · 2024: 44 · 2023: 36 · 2022: 45 · 2021: 61 · 2020: 32 · 2019: 13 · 2018: 15 · 2017: 20 · 2016: 11 · 2015: 9 · 2014: 13 · 2013: 12 · 2012: 12
- FWCI
- 1.41
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Molecules (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
- Topics
- Life Sciences › Immunology and Microbiology › Microbiology › Antimicrobial Peptides and Activities
- Life Sciences › Immunology and Microbiology › Immunology › interferon and immune responses
- Health Sciences › Nursing › Nutrition and Dietetics › Infant Nutrition and Health
- Keywords
- lactoferrin, antiviral activity, iron-binding glycoprotein, heparan sulfate, viral entry inhibition, mucosal immunity, nuclear localization, viral infection, innate immunity
- MeSH terms
- Animals, Antiviral Agents, Binding Sites, Cats, Cattle, Female, Heparan Sulfate, Humans, Immunity, Innate, Iron Chelating Agents, Lactoferrin, Models, Molecular, Protein Binding, Virus Diseases, Virus Replication, Viruses, Mice, Rats, Virus Internalization
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.